Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical OfficerGlobe Newswire•27/07/2026•08:00 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?
